Literature DB >> 26471367

Market watch: Where is personalized medicine in industry heading?

Christopher-Paul Milne1, Joshua P Cohen1, Ranjana Chakravarthy1.   

Abstract

Mesh：

Year:  2015        PMID： 26471367     DOI： 10.1038/nrd4759

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Trial watch: integrin antagonist shows promise in MS.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694
  1 in total
  6 in total

Review 1.  Companion diagnostics-a tool to improve pharmacotherapy.

Authors:  Jan Trøst Jørgensen; Maria Hersom
Journal:  Ann Transl Med       Date:  2016-12

2.  The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).

Authors:  Talia Golan; Michele Milella; Aliza Ackerstein; Ranaan Berger
Journal:  J Exp Clin Cancer Res       Date:  2017-12-28

Review 3.  Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.

Authors:  Christophe Bounaix Morand du Puch; Mathieu Vanderstraete; Stéphanie Giraud; Christophe Lautrette; Niki Christou; Muriel Mathonnet
Journal:  Theranostics       Date:  2021-09-21       Impact factor: 11.556

4.  Dissecting the Business Case for Adoption and Implementation of Digital Pathology: A White Paper from the Digital Pathology Association.

Authors:  Giovanni Lujan; Jennifer C Quigley; Douglas Hartman; Anil Parwani; Brian Roehmholdt; Bryan Van Meter; Orly Ardon; Matthew G Hanna; Dan Kelly; Chelsea Sowards; Michael Montalto; Marilyn Bui; Mark D Zarella; Victoria LaRosa; Gerard Slootweg; Juan Antonio Retamero; Mark C Lloyd; James Madory; Doug Bowman
Journal:  J Pathol Inform       Date:  2021-04-07

5.  Fingerprinting Acute Digestive Diseases by Untargeted NMR Based Metabolomics.

Authors:  Panteleimon G Takis; Antonio Taddei; Riccardo Pini; Stefano Grifoni; Francesca Tarantini; Paolo Bechi; Claudio Luchinat
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 5.923

6.  Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression.

Authors:  Jungwhoi Lee; Jungsul Lee; Woogwang Sim; Jae-Hoon Kim
Journal:  Cancers (Basel)       Date:  2020-01-23       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.